References
-
1) Berberine promotes the viability of random skin flaps via the PI3K/Akt/eNOS signaling pathway.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: PHYTOTHER RESImpactFactor: 6.1DOI: 10.1002/ptr.7621PMID: 36116786 -
2) Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2023.110849PMID: 37633241 -
3) Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: iScienceImpactFactor: 5.8DOI: 10.1016/j.isci.2023.108092PMID: 37876799 -
4) The eNOS-induced leonurine's new role in improving the survival of random skin flap.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2023.111037PMID: 37827057 -
5) CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Arch Biochem BiophysImpactFactor: 3.8DOI: 10.1016/j.abb.2023.109701PMID: 37499993 -
6) Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: J Cell Mol MedImpactFactor: 5.3DOI: 10.1111/jcmm.17678PMID: 36729917 -
7) Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: PHYTOMEDICINEImpactFactor: 6.7DOI: 10.1016/j.phymed.2022.154517PMID: 36332390 -
8) Extracellular vesicles from hypoxia-pretreated adipose-derived stem cells regulate hypoxia/reoxygenation-induced human dermal microvascular endothelial apoptosis and autophagy in vitro.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: HELIYONImpactFactor: 4DOI: 10.1016/j.heliyon.2023.e13315PMID: 36747525 -
9) Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRβ signaling in cancer-associated fibroblasts.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: J ETHNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.jep.2022.115825PMID: 36240978 -
10) Saxagliptin promotes random skin flap survival.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Int ImmunopharmacolImpactFactor: 4.8DOI: 10.1016/j.intimp.2023.110364PMID: 37224651 -
11) Aliskiren promotes skin-flap survival.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: INT IMMUNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.intimp.2023.109851 -
12) Roxadustat promotes hypoxia-inducible factor-1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Int Wound JImpactFactor: 2.6DOI: 10.1111/iwj.14235PMID: 37225176 -
13) Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral head.
Product: VEGFA Antibody (#AF5131)Year: 2023Journal: Front Cell Dev BiolImpactFactor: 4.6DOI: 10.3389/fcell.2023.1251634PMID: 37876552 -
14) Electroacupuncture suppresses spinal nerve ligation-induced neuropathic pain via regulation of synaptic plasticity through upregulation of basic fibroblast growth factor expression.
Product: VEGFA Antibody (#AF5131)Year: 2022Journal: ACUPUNCT MEDImpactFactor: 2.4DOI: 10.1177/09645284211066499PMID: 35100811 -
15) Biejiajian Pill Inhibits Progression of Chronic Inflammation-Related Hepatocellular Carcinoma by Downregulating PDGFRβ Signaling.